We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

118 hedge funds and large institutions have $1.12B invested in Myovant Sciences Ltd. in 2022 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more capital invested

Capital invested by funds: $548M → $1.12B (+$576M)

77% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 31

20% more funds holding

Funds holding: 98 → 118 (+20)

18% more call options, than puts

Call options by funds: $18.1M | Put options by funds: $15.3M

4% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 26

Holders
118
Holders Change
+20
Holders Change %
+20.41%
% of All Funds
1.9%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
% of All Funds
0.13%
New
55
Increased
27
Reduced
26
Closed
31
Calls
$18.1M
Puts
$15.3M
Net Calls
+$2.8M
Net Calls Change
+$6.43M

Top Buyers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
+$227M
2
Goldman Sachs
Goldman Sachs
New York
+$50.8M
3
CC
Carlson Capital
Texas
+$47.5M
4
AA
AQR Arbitrage
Connecticut
+$36.5M
5
NAM
Nexpoint Asset Management
Texas
+$35.2M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$177M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$98.2M
3
Citadel Advisors
Citadel Advisors
Florida
-$22.9M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9.09M
5
PIM
Platinum Investment Management
Australia
-$5.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
GF
26
Gabelli Funds
New York
$7.88M +$7.69M +292,400 New
FSI
27
Flow State Investments
Illinois
$7.55M +$7.37M +280,010 New
Rafferty Asset Management
28
Rafferty Asset Management
New York
$7.46M +$3.01M +114,534 +71%
Voloridge Investment Management
29
Voloridge Investment Management
Florida
$7.3M +$3.73M +141,729 +110%
TRCT
30
Tower Research Capital (TRC)
New York
$7.26M +$3.78M +143,775 +115%
VI
31
Versor Investments
New York
$7.02M +$6.85M +260,396 New
CS
32
Credit Suisse
Switzerland
$6.31M +$5.19M +197,360 +539%
Charles Schwab
33
Charles Schwab
California
$6.08M +$206K +7,819 +4%
Barclays
34
Barclays
United Kingdom
$4.88M +$2.12M +80,746 +81%
Millennium Management
35
Millennium Management
New York
$4.47M +$4M +152,094 +1,121%
EFI
36
EHP Funds Inc
Canada
$4.24M +$4.14M +157,228 New
Two Sigma Advisers
37
Two Sigma Advisers
New York
$3.57M +$3.49M +132,500 New
Two Sigma Investments
38
Two Sigma Investments
New York
$3.54M +$2.69M +102,374 +353%
HWAM
39
Hennion & Walsh Asset Management
New Jersey
$3.41M -$3.72M -141,504 -53%
Citigroup
40
Citigroup
New York
$3.31M -$704K -26,767 -18%
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$3.05M +$2.97M +113,050 New
TC
42
Trium Capital
United Kingdom
$2.95M +$2.88M +109,482 New
Swiss National Bank
43
Swiss National Bank
Switzerland
$2.81M +$65.8K +2,500 +2%
GI
44
GAMCO Investors
Connecticut
$2.8M +$2.73M +103,879 New
Northern Trust
45
Northern Trust
Illinois
$2.76M +$93.4K +3,549 +4%
Citadel Advisors
46
Citadel Advisors
Florida
$2.7M -$22.9M -870,046 -90%
GCIA
47
Gabelli & Co Investment Advisers
New York
$2.22M +$2.17M +82,450 New
PCM
48
Prelude Capital Management
New York
$2.06M +$2.01M +76,274 New
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$1.95M +$1.9M +72,421 New
JF
50
Jump Financial
Illinois
$1.95M -$472K -17,930 -20%
1
2
3 4 5

MYOV Hedge Fund Activity: Q4 2022 in Review

118 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2022, worth a combined $1.12B — up 105% from $548M a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new MYOV positions and 31 closed out — a net gain of 24 holders — while 27 added to existing stakes and 26 trimmed.

The largest buyer was Fidelity International, opening a new position worth an estimated $227M. The largest seller was Janus Henderson Group, cutting an estimated $177M.

  • 118 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2022, up from 98 in Q3 2022.
  • Funds reported $1.12B of Myovant Sciences Ltd. stock for Q4 2022, up 105% quarter-over-quarter.
  • 55 funds opened new Myovant Sciences Ltd. positions in Q4 2022 and 31 closed out, a net change of +24 holders.
  • The largest Myovant Sciences Ltd. buyer in Q4 2022 was Fidelity International, an estimated $227M added.
  • The largest Myovant Sciences Ltd. seller in Q4 2022 was Janus Henderson Group, an estimated $177M sold.

Based on aggregated 13F filings for Q4 2022.